Published in Indian Pediatr on July 01, 2007
Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res (2011) 2.36
Do Indian children need pneumococcal vaccination? Indian Pediatr (2007) 1.16
Pneumococcal conjugate vaccine: a newer vaccine available in India. Hum Vaccin Immunother (2012) 0.98
Universal pneumococcal vaccination for India. Indian Pediatr (2008) 0.97
Universal pneumococcal vaccination in India: is it a priority? Indian Pediatr (2008) 0.96
Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis (2013) 0.87
Pneumococcal vaccination: yes or no. Indian Pediatr (2008) 0.75
Pneumococcal vaccine in India. Indian Pediatr (2008) 0.75
Pneumococcal conjugate vaccine--relevance for developing countries. Indian Pediatr (2001) 4.11
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (2009) 4.81
Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med (2010) 3.25
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine (2003) 2.87
A call to action for the new decade of vaccines. Lancet (2011) 2.72
Development and use of the Lives Saved Tool (LiST): a model to estimate the impact of scaling up proven interventions on maternal, neonatal and child mortality. Int J Epidemiol (2010) 2.60
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med (2013) 2.54
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J (2006) 2.10
Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. Lancet Infect Dis (2010) 1.82
The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study. Clin Infect Dis (2012) 1.78
Methodological and quality issues in epidemiological studies of acute lower respiratory infections in children in developing countries. Int J Epidemiol (2004) 1.72
Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights (2009) 1.67
Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health Aff (Millwood) (2011) 1.52
Sensitivity of hospital-based surveillance for severe disease: a geographic information system analysis of access to care in Kilifi district, Kenya. Bull World Health Organ (2010) 1.49
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Geographic access to care is not a determinant of child mortality in a rural Kenyan setting with high health facility density. BMC Public Health (2010) 1.46
During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Aff (Millwood) (2011) 1.46
Effectiveness of pneumococcal conjugate vaccine. Lancet (2006) 1.45
Vaccines to prevent pneumonia and improve child survival. Bull World Health Organ (2008) 1.44
Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable? Vaccine (2010) 1.43
The future of immunisation policy, implementation, and financing. Lancet (2011) 1.36
Identification and selection of cases and controls in the Pneumonia Etiology Research for Child Health project. Clin Infect Dis (2012) 1.33
The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya. Vaccine (2012) 1.30
Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project. Clin Infect Dis (2012) 1.28
Breathing new life into pneumonia diagnostics. J Clin Microbiol (2009) 1.28
Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med (2009) 1.28
A review of vaccine research and development: human acute respiratory infections. Vaccine (2005) 1.27
The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine (2011) 1.26
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine (2012) 1.26
Specimen collection for the diagnosis of pediatric pneumonia. Clin Infect Dis (2012) 1.26
A literature review and survey of childhood pneumonia etiology studies: 2000-2010. Clin Infect Dis (2012) 1.21
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis (2007) 1.19
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Standardizing surveillance of pneumococcal disease. Clin Infect Dis (2009) 1.12
Computerized lung sound analysis as diagnostic aid for the detection of abnormal lung sounds: a systematic review and meta-analysis. Respir Med (2011) 1.12
Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. PLoS Med (2012) 1.09
Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis (2009) 1.08
Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. Vaccine (2010) 1.08
Evaluation of risk factors for severe pneumonia in children: the Pneumonia Etiology Research for Child Health study. Clin Infect Dis (2012) 1.07
Comparison of molecular and conventional methods for typing of enteroviral isolates. J Clin Microbiol (2002) 1.07
Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis (2003) 1.06
Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study. Clin Infect Dis (2009) 1.05
Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. Hum Vaccin (2006) 1.05
Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr (2003) 1.03
PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries. J Health Popul Nutr (2004) 1.02
The role of postmortem studies in pneumonia etiology research. Clin Infect Dis (2012) 1.01
Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. Emerg Infect Dis (2004) 1.01
Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014. MMWR Morb Mortal Wkly Rep (2014) 0.99
The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis. Vaccine (2012) 0.99
A policy framework for accelerating adoption of new vaccines. Hum Vaccin (2010) 0.98
Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Rev Panam Salud Publica (2006) 0.94
Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia. Diagn Microbiol Infect Dis (2005) 0.93
Liver transplantation for acute intermittent porphyria: a viable treatment? Hepatobiliary Pancreat Dis Int (2010) 0.91
Clinical manifestations of HIV-1 infection. Indian Pediatr (2002) 0.89
Pneumonia etiology research for child health. Introduction. Clin Infect Dis (2012) 0.89
Describing the epidemiology and aetiology of bacterial pneumonia in children: an unresolved problem. J Health Popul Nutr (2005) 0.88
Evaluation of a one-tube RT-PCR system for detection of enteroviruses. J Clin Virol (2002) 0.88
Poor awareness of symptoms of oesophageal cancer. Interact Cardiovasc Thorac Surg (2010) 0.88
Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. Vaccine (2006) 0.87
A pilot study on the seroprevalence of parvovirus B19 infection. Indian J Med Res (2002) 0.86
Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens. J Microbiol Methods (2014) 0.86
Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J (2004) 0.83
Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med (2009) 0.82
Reemergence, in southwestern Alaska, of invasive Haemophilus influenzae type b disease due to strains indistinguishable from those isolated from vaccinated children. J Infect Dis (2002) 0.82
Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries. Hum Vaccin (2010) 0.81
Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J (2009) 0.81
Rationale and expectations of the Pneumonia Etiology Research for Child Health (PERCH) study. Expert Rev Respir Med (2011) 0.81
Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health (2013) 0.79
Editorial: Breathing new life into pneumonia epidemiology. Am J Epidemiol (2009) 0.78
Sensitivity of surveillance for Haemophilus influenzae Type b meningitis. Pediatr Infect Dis J (2006) 0.78
Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. J Virol Methods (2013) 0.77
Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients. Indian J Gastroenterol (2014) 0.77
Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention. Vaccine (2013) 0.76
The changing landscape of epidemic bacterial meningitis in Africa: new opportunities for prevention. J Infect Dis (2005) 0.75
The role of health care in the spread of HIV/AIDS in Africa: evidence from Kenya. Int J STD AIDS (2007) 0.75
A new old opportunity for preventing serious group A streptococcal infections. Clin Infect Dis (2005) 0.75
Response to Moore and others (2010) and Mehta (2010). Am J Trop Med Hyg (2011) 0.75
Defining the burden of Hib disease in India. Indian Pediatr (2002) 0.75
An outbreak of echovirus meningitis in children. Indian Pediatr (2004) 0.75
Global Epidemiology of Diphtheria, 2000-2017. Emerg Infect Dis (2019) 0.75
Pneumonia prevention gets a fresh opportunity. Int J Tuberc Lung Dis (2009) 0.75